Please note that this website will be undergoing technical maintenance between 28 and 31 August. Consequently, users may experience instabilities and limited functionality. We apologise for the inconvenience.
For a better user experience please update your browser or use Chrome or Firefox browser.
Utilities
Publication detail
Home
Case T-393/23 R: Order of the President of the General Court of 1 September 2023– Teva v Commission (Interim relief — Medicinal products for human use — Marketing authorisation — Application for interim measures — Lack of urgency)
Case T-393/23 R: Order of the President of the General Court of 1 September 2023– Teva v Commission (Interim relief — Medicinal products for human use — Marketing authorisation — Application for interim measures — Lack of urgency)
Publication metadata
- Published:
- Corporate author(s): General Court (Court of Justice of the European Union)
- Subject: drug surveillance , generic drug , market approval
- IMMC : ORD-T-0393-2023
- CELEX : 62023TB0393
- OJ : C_202300341
- ELI : C/2023/341/oj
|
pdfa2a
|
|||
| ISSN 1977-091X | ISBN | DOI | Catalogue number FXC2300341EN |
Document viewer
Note:
The publication cannot be displayed in the document viewer. Open web version
You may access it from: Download and languages